FRINK Linked Data Fragments server

Matches in SemOpenAlex for { <https://semopenalex.org/work/W4205755377> ?p ?o ?g. }

• W4205755377 endingPage "101826" @default.
• W4205755377 startingPage "101826" @default.
• W4205755377 abstract "Severe acute respiratory syndrome coronavirus disease (SARS-CoV-2) induced coronavirus disease 2019 (COVID-19) pandemic is the present worldwide health emergency. The global scientific community faces a significant challenge in developing targeted therapies to combat the SARS-CoV-2 infection. Computational approaches have been critical for identifying potential SARS-CoV-2 inhibitors in the face of limited resources and in this time of crisis. Main protease (Mpro) is an intriguing drug target because it processes the polyproteins required for SARS-CoV-2 replication. The application of Ayurvedic knowledge from traditional Indian systems of medicine may be a promising strategy to develop potential inhibitor for different target proteins of SARS-CoV-2. With this endeavor, we docked bioactive molecules from Triphala, an Ayurvedic formulation, against Mpro followed by molecular dynamics (MD) simulation (100 ns) to investigate their inhibitory potential against SARS-CoV-2. The top four best docked molecules (terflavin A, chebulagic acid, chebulinic acid, and corilagin) were selected for MD simulation study and the results obtained were compared to native ligand X77. From docking and MD simulation studies, the selected molecules showed promising binding affinity with the formation of stable complexes at the active binding pocket of Mpro and exhibited negative binding energy during MM-PBSA calculations, indication their strong binding affinity with the target protein. The identified bioactive molecules were further analyzed for drug-likeness by Lipinski's filter, ADMET and toxicity studies. Computational (in silico) investigations identified terflavin A, chebulagic acid, chebulinic acid, and corilagin from Triphala formulation as promising inhibitors of SARS-CoV-2 Mpro, suggesting experimental (in vitro/in vivo) studies to further explore their inhibitory mechanisms." @default.
• W4205755377 created "2022-01-25" @default.
• W4205755377 creator A5003003860 @default.
• W4205755377 creator A5008343320 @default.
• W4205755377 creator A5023057502 @default.
• W4205755377 creator A5029063228 @default.
• W4205755377 creator A5038721436 @default.
• W4205755377 creator A5040037801 @default.
• W4205755377 creator A5040315799 @default.
• W4205755377 creator A5041701268 @default.
• W4205755377 creator A5046645647 @default.
• W4205755377 creator A5060830379 @default.
• W4205755377 creator A5062601333 @default.
• W4205755377 creator A5071236833 @default.
• W4205755377 creator A5077506413 @default.
• W4205755377 creator A5081575310 @default.
• W4205755377 creator A5081764697 @default.
• W4205755377 date "2022-04-01" @default.
• W4205755377 modified "2023-10-18" @default.
• W4205755377 title "Identification of bioactive molecules from Triphala (Ayurvedic herbal formulation) as potential inhibitors of SARS-CoV-2 main protease (Mpro) through computational investigations" @default.
• W4205755377 cites W1031578623 @default.
• W4205755377 cites W1974229648 @default.
• W4205755377 cites W2000189060 @default.
• W4205755377 cites W2004343588 @default.
• W4205755377 cites W2009423060 @default.
• W4205755377 cites W2029667189 @default.
• W4205755377 cites W2044172327 @default.
• W4205755377 cites W2050564499 @default.
• W4205755377 cites W2100593398 @default.
• W4205755377 cites W2102377211 @default.
• W4205755377 cites W2125976303 @default.
• W4205755377 cites W2135732933 @default.
• W4205755377 cites W2142077465 @default.
• W4205755377 cites W2157563194 @default.
• W4205755377 cites W2161572568 @default.
• W4205755377 cites W2271736303 @default.
• W4205755377 cites W2591473713 @default.
• W4205755377 cites W2735538939 @default.
• W4205755377 cites W2752012398 @default.
• W4205755377 cites W2764298028 @default.
• W4205755377 cites W2801088198 @default.
• W4205755377 cites W2884104807 @default.
• W4205755377 cites W2886516169 @default.
• W4205755377 cites W2902225381 @default.
• W4205755377 cites W2912818999 @default.
• W4205755377 cites W2964743285 @default.
• W4205755377 cites W2989212116 @default.
• W4205755377 cites W2991793847 @default.
• W4205755377 cites W2998826459 @default.
• W4205755377 cites W3023763448 @default.
• W4205755377 cites W3025917451 @default.
• W4205755377 cites W3042507426 @default.
• W4205755377 cites W3046286130 @default.
• W4205755377 cites W3088771441 @default.
• W4205755377 cites W3092006589 @default.
• W4205755377 cites W3095307126 @default.
• W4205755377 cites W3113583457 @default.
• W4205755377 cites W3120282442 @default.
• W4205755377 cites W3120641136 @default.
• W4205755377 cites W3132116837 @default.
• W4205755377 cites W3134028605 @default.
• W4205755377 cites W3134381594 @default.
• W4205755377 cites W3143120081 @default.
• W4205755377 cites W3153093973 @default.
• W4205755377 cites W3153959554 @default.
• W4205755377 cites W3154456855 @default.
• W4205755377 cites W3159720326 @default.
• W4205755377 cites W3165437798 @default.
• W4205755377 cites W3166315429 @default.
• W4205755377 cites W3168033840 @default.
• W4205755377 cites W3171090371 @default.
• W4205755377 cites W3174922262 @default.
• W4205755377 cites W3180063515 @default.
• W4205755377 cites W3194103799 @default.
• W4205755377 cites W3203573859 @default.
• W4205755377 cites W3204927697 @default.
• W4205755377 cites W3211258325 @default.
• W4205755377 cites W4200468895 @default.
• W4205755377 doi "https://doi.org/10.1016/j.jksus.2022.101826" @default.
• W4205755377 hasPubMedId "https://pubmed.ncbi.nlm.nih.gov/35035181" @default.
• W4205755377 hasPublicationYear "2022" @default.
• W4205755377 type Work @default.
• W4205755377 citedByCount "33" @default.
• W4205755377 countsByYear W42057553772022 @default.
• W4205755377 countsByYear W42057553772023 @default.
• W4205755377 crossrefType "journal-article" @default.
• W4205755377 hasAuthorship W4205755377A5003003860 @default.
• W4205755377 hasAuthorship W4205755377A5008343320 @default.
• W4205755377 hasAuthorship W4205755377A5023057502 @default.
• W4205755377 hasAuthorship W4205755377A5029063228 @default.
• W4205755377 hasAuthorship W4205755377A5038721436 @default.
• W4205755377 hasAuthorship W4205755377A5040037801 @default.
• W4205755377 hasAuthorship W4205755377A5040315799 @default.
• W4205755377 hasAuthorship W4205755377A5041701268 @default.
• W4205755377 hasAuthorship W4205755377A5046645647 @default.
• W4205755377 hasAuthorship W4205755377A5060830379 @default.
• W4205755377 hasAuthorship W4205755377A5062601333 @default.
• W4205755377 hasAuthorship W4205755377A5071236833 @default.

• next